CRIBL laboratory congratulates Christelle Vincent-Fabert, CNRS researcher and member of the 2MB2C team, for her participation as a speaker at the Waldenström macroglobulinemia Workshop, held on March 19 and 20, 2026, at the Palais des Congrès in Paris.

An Event Dedicated to Waldenström Disease

This free workshop brought together researchers, clinicians, students, and patients to explore the fundamental mechanisms of Waldenström macroglobulinemia (WM), innovative therapeutic approaches, and a patient-oriented session. The Waldenström France association thanked the key contributors present for fostering dialogue between fundamental research, therapeutic innovation, and patient experience.

Recognized Expertise of Christelle Vincent-Fabert

Christelle Vincent-Fabert presented her project on “Modulation of the immunosuppressive microenvironment by ibrutinib in a mouse model.” A specialist in indolent lymphomas such as WM—for which she received the Young Researcher Award in 2019—her work on animal models and molecular mechanisms enhances CRIBL’s visibility in B-cell hematological disorders.

This presentation highlights CRIBL’s advances in translational research in hematology and lymphoid oncology.

Learn more:

https://waldenstromfrance.org/lassociation-wf/presentation/